Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Completed · Phase 3

Conditions studied: Onychomycosis of Toenails

In brief

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Key facts

Study ID

NCT01302119

Run by

Pfizer

People needed

604

Starts

2011-02-01

Expected to finish

2013-02-20

Last updated by the study team

2019-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of distal subungual onychomycosis affecting at least one great toenail
• KOH positive at screening
• Willingness not to use any other products including nail polish applied to the toenails during the study
• Women of childbearing potential who are currently sexually active must agree to use contraception for the entire study period

You may not qualify if…

• Concurrent or recent use of certain topical or systemic medications without a sufficient washout period
• History of any significant chronic fungal disease other than onychomycosis
• Significant confounding conditions as assessed by study doctor
• Participated in any other trial of an investigational drug or device within 30 days or participation in a research study concurrent with this study
• Pregnancy or lactation

Where it is running

• Investigational Site — Phoenix, Arizona, United States
• Investigational Site — Novato, California, United States
• Investigational Site — Oceanside, California, United States
• Investigational Site — San Diego, California, United States
• Investigational Site — San Francisco, California, United States
• Investigational Site — Santa Rosa, California, United States
• Investigational Site — Miami, Florida, United States
• Investigational Site — Miami, Florida, United States
• Investigational Site — Nampa, Idaho, United States
• Investigational Site — Evansville, Indiana, United States
• Investigational Site — Ann Arbor, Michigan, United States
• Investigational Site — St Louis, Missouri, United States
• Investigational Site — Verona, New Jersey, United States
• Investigational Site — Albuquerque, New Mexico, United States
• Investigational Site — High Point, North Carolina, United States
• Investigational Site — Raleigh, North Carolina, United States
• Investigational Site — Columbus, Ohio, United States
• Investigational Site — Portland, Oregon, United States
• Investigational Site — Philadelphia, Pennsylvania, United States
• Investigational Site — Greer, South Carolina, United States
• Investigational Site — Knoxville, Tennessee, United States
• Investigational Site — Dallas, Texas, United States
• Investigational Site — San Antonio, Texas, United States
• Investigational Site — Salt Lake City, Utah, United States
• Investigational Site — Harrisonburg, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.